Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Inflammatory Markers in Exhaled Breath (Condensate) in Childhood Asthma

This study has been completed.
Sponsor:
Collaborator:
AstraZeneca
Information provided by:
Maastricht University Medical Center
ClinicalTrials.gov Identifier:
NCT00404976
First received: November 28, 2006
Last updated: NA
Last verified: November 2003
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: April 2005
  Estimated Primary Completion Date: No date given